Pre-transplant risk factors predicting post-transplant cytomegalovirus infection in liver transplant recipients

7Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Cytomegalovirus (CMV) infection causes significant morbidity and mortality among transplant recipients. Although it is still not clear if a preemptive strategy is superior to a prophylactic strategy, many transplant programs elect for preemptive treatment for post-transplant CMV infection. In order to improve the preemptive strategy, we analyzed a series of liver recipients by means of quantitative real-time polymerase chain reaction (PCR). Ninety-one liver transplant recipients were monitored by real-time PCR for CMV, and the results were analyzed in terms of preoperative conditions. Multivariate analysis revealed fulminant hepatic failure as an underlying disease (odds ratio, 6.8; 95% CI, 1.2-39.2), while an ABO-incompatible graft (odds ratio, 5.0; 95% CI, 1.3-19.1), and a serological combination of the donor (D) being positive with the recipient (R) being negative for CMV (D+/R-) (odds ratio, 5.8; 95% CI, 1.3-26.0) were independently associated with the development of significant CMV infection. Patients with risk factors had higher peak CMV DNA concentrations than those without, and developed CMV infections faster (P = 0.0002). Screening of recipients according to risk factors and PCR monitoring may result in an optimization of the preemptive strategy. © 2007 The Authors.

Cite

CITATION STYLE

APA

Saito, T., Egawa, H., Kudo, T., Takakura, S., Fujihara, N., Iinuma, Y., & Ichiyama, S. (2007). Pre-transplant risk factors predicting post-transplant cytomegalovirus infection in liver transplant recipients. Transplant International, 20(5), 419–424. https://doi.org/10.1111/j.1432-2277.2007.00459.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free